The spin out companies are engineering viruses to seek and destroy cancer cells and using bacteria to break down the physical defences of tumours.
Widely-used anti-inflammatory drugs make tumours in mice more responsive to treatments that harness the power of the body’s own immune system to tackle cancer, according to research funded by Cancer Research UK and published in the journal Cancer Discovery.
Cancer Research UK’s spinout, Achilles Therapeutics plc (‘Achilles’), has raised $175.5 million through the closing of its initial public offering (IPO).
Cancer Research UK scientists have invented a new experimental drug that aims to harness the full power of the body’s own immune system.
Scientists may have found a way to pull down the protective wall that surrounds tumours, potentially re-exposing them to the killing power of the immune system.
Injecting immune cell stimulants directly into a tumour could help the immune system spot and attack cancer cells, according to new research in mice.
An immunotherapy drug has shown promise for the first time in a form of aggressive breast cancer.
Scientists have shown for the first time that immune cells in the urine of bladder cancer patients accurately reflect those in the tumour environment.
A joint UK and European research project launches today to combat liver cancer, which is the fastest rising cause of cancer death in the UK.
A first of its kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell lung cancer.